TP53 and diffuse large B-cell lymphoma: Our study contributes to the expanding body of literature on DLBCL in Hispanic patients by elucidating the prevalence of TP53, CREBBP, and NOTCH1 mutations, among other genes within our cohort, diverging from established trends observed in diverse populations.